Target type: molecularfunction
Combining with amylin to initiate a change in cell activity. [GOC:bhm, PMID:10871296, PMID:12037140, PMID:18687416]
Amylin receptor activity refers to the ability of a receptor protein to bind and respond to the peptide hormone amylin. Amylin, also known as islet amyloid polypeptide (IAPP), is produced by beta cells in the pancreas and plays a crucial role in glucose homeostasis.
When amylin binds to its receptor, a complex signaling cascade is initiated. This cascade involves the activation of various intracellular pathways, leading to a diverse range of physiological effects. Some of the key molecular functions associated with amylin receptor activity include:
* **Inhibition of glucagon secretion:** Amylin receptor activation suppresses the release of glucagon, a hormone that raises blood glucose levels. This action contributes to the overall lowering of blood glucose.
* **Regulation of insulin secretion:** Amylin receptor activity modulates insulin secretion, albeit to a lesser extent than glucagon suppression. This effect is complex and can vary depending on the specific conditions.
* **Appetite suppression:** Amylin receptor signaling contributes to a decrease in appetite and food intake by acting on regions of the brain responsible for satiety.
* **Gastrointestinal motility control:** Amylin receptor activation influences the rate of gastric emptying and intestinal motility, potentially contributing to the regulation of nutrient absorption.
* **Cellular protection:** Some studies suggest that amylin receptor signaling might have protective effects on pancreatic beta cells and other cell types, potentially through mechanisms involving anti-inflammatory and anti-apoptotic pathways.
Overall, amylin receptor activity plays a multifaceted role in regulating glucose metabolism, appetite control, and gastrointestinal function. Its involvement in various cellular processes highlights the importance of this receptor in maintaining metabolic homeostasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Calcitonin receptor | A calcitonin receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P30988] | Homo sapiens (human) |
Receptor activity-modifying protein 3 | A receptor activity-modifying protein 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60896] | Homo sapiens (human) |
Receptor activity-modifying protein 1 | A receptor activity-modifying protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60894] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
telcagepant | telcagepant: structure in first source | ||
mk 3207 | |||
bms 694153 | |||
mk-8825 | |||
atogepant | atogepant : A secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine. | azaspiro compound; organic heterotetracyclic compound; piperidones; secondary carboxamide; trifluorobenzene | calcitonin gene-related peptide receptor antagonist |